Drug Shortage Report for APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
Report ID | 185951 |
Drug Identification Number | 02509423 |
Brand name | APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE |
Common or Proper name | SITAGLIPTAN MALATE/METFORMIN |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | METFORMIN HYDROCHLORIDE SITAGLIPTIN |
Strength(s) | 850MG 50MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 60 BTL |
ATC code | A10BD |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2023-03-03 |
Estimated end date | 2023-10-06 |
Actual end date | 2023-10-05 |
Shortage status | Resolved |
Updated date | 2023-10-06 |
Company comments | Product on allocation due to increased demand |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2023-03-04 | English | Compare |
v2 | 2023-03-02 | French | Compare |
v1 | 2023-03-02 | English | Compare |